Magdadaro, Krizza Lou L.

HRN: 26-72-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2025
CEFTRIAXONE 1G (VIAL)
02/27/2025
02/21/2025
IV
1g
Once
Prophylaxis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: